Patient Capital Management’s Capital One COF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-252,467
Closed -$37.6M 41
2024
Q1
$37.6M Sell
252,467
-69,425
-22% -$9.4M 1.83% 27
2023
Q4
$42.2M Sell
321,892
-43,491
-12% -$4.69M 2.24% 21
2023
Q3
$35.5M Sell
365,383
-53,792
-13% -$5.75M 2.08% 23
2023
Q2
$45.8M Buy
419,175
+378,475
+930% +$37.9M 2.55% 20
2023
Q1
$3.91M Buy
40,700
+12,000
+42% +$1.26M 1.74% 30
2022
Q4
$2.67M Hold
28,700
1.3% 32
2022
Q3
$2.65M Sell
28,700
-2,350
-8% -$250K 1.32% 32
2022
Q2
$3.23M Buy
31,050
+950
+3% +$116K 1.43% 31
2022
Q1
$3.95M Hold
30,100
1.34% 32
2021
Q4
$4.37M Buy
+30,100
New +$4.65M 1.26% 32

Other funds holding COF

Patient Capital Management's COF Position: Q2 2024 in Review

Patient Capital Management sold out of Capital One (COF) in Q2 2024, closing a stake of 252,467 shares — an estimated $37.6M sold.

Patient Capital Management first reported a position in COF in Q4 2021 and held it in 10 quarters. The position peaked at $45.8M in Q2 2023. 1,196 funds tracked by Wall St. Rank hold COF as of Q2 2024.

  • Patient Capital Management reported no remaining Capital One position as of Q2 2024 after selling out during the quarter.
  • Patient Capital Management sold 252,467 Capital One shares in Q2 2024, an estimated $37.6M.
  • Patient Capital Management first reported a position in Capital One in Q4 2021 and held it in 10 quarters.
  • Patient Capital Management's Capital One position peaked at $45.8M in Q2 2023.
  • 1,196 funds tracked by Wall St. Rank held Capital One as of Q2 2024.

Based on Patient Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.